Results per Page:
Artificial intelligence takes on neurodendocrine prostate cancer diagnosis
From Dr. Michael Haffner and colleagues, Human Biology and Clinical Research Divisions
Seattle architect was shocked when diagnosed with a rare lung cancer at 31
A second opinion and proton therapy were key to eradicating a neuroendocrine tumor
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
In cancer, the context 'makes' the mutation
Whether a mutated gene suppresses or promotes small-cell lung cancer depends on other mutations